(WST) |
| 0 (0%) 01-13 20:27 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 291.12 |
| Resistance 1: | 280.52 |
| Pivot price: | 276.08 |
| Support 1: | 263.38 |
| Support 2: | 219.13 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 6.740 |
| Book Value | 42.440 |
| PEG Ratio | 0.00 |
| Gross Profit | 14.874 |
| Profit Margin (%) | 16.29 |
| Operating Margin (%) | 21.85 |
| Return on Assets (ttm) | 10.2 |
| Return on Equity (ttm) | 16.9 |
Company news
Tue, 13 Jan 2026
Wall Street Analysts See a 26.42% Upside in West Pharmaceutical (WST): Can the Stock Really Move This High? - Finviz
Tue, 13 Jan 2026
TD Cowen Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Maintains Target Price $350 - 富途牛牛
Mon, 12 Jan 2026
COO or WST: Which Is the Better Value Stock Right Now? - Yahoo Finance
Mon, 12 Jan 2026
West Pharmaceutical (WST) to Sell SmartDose System Rights to Abb - GuruFocus
Mon, 12 Jan 2026
AbbVie to buy Arizona manufacturing facility from West Pharmaceutical (WST:NYSE) - Seeking Alpha
Mon, 12 Jan 2026
Drugmaker bringing 200 jobs to Arizona plant for next-gen medicines - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
